THBD and COVID-19: These results rationalize a detailed analysis of EC-expressed procoagulative and inflammatory factors and the potential role of targeting thrombomodulin, TNF-α, and E-selectin in resolving EC-directed COVID-19 coagulation and inflammation (3, 4, 20, 26).